Cargando…

Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia

Detalles Bibliográficos
Autores principales: Rankine-Mullings, Angela, Keenan, Russell, Chakravorty, Subarna, Inusa, Baba, Telfer, Paul, Velangi, Mark, Ware, Russell E., Moss, Jon J., Lloyd, Adam L., Edwards, Sarah, Mulla, Hussain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424132/
https://www.ncbi.nlm.nih.gov/pubmed/37171600
http://dx.doi.org/10.1182/bloodadvances.2023010099
_version_ 1785089608320548864
author Rankine-Mullings, Angela
Keenan, Russell
Chakravorty, Subarna
Inusa, Baba
Telfer, Paul
Velangi, Mark
Ware, Russell E.
Moss, Jon J.
Lloyd, Adam L.
Edwards, Sarah
Mulla, Hussain
author_facet Rankine-Mullings, Angela
Keenan, Russell
Chakravorty, Subarna
Inusa, Baba
Telfer, Paul
Velangi, Mark
Ware, Russell E.
Moss, Jon J.
Lloyd, Adam L.
Edwards, Sarah
Mulla, Hussain
author_sort Rankine-Mullings, Angela
collection PubMed
description
format Online
Article
Text
id pubmed-10424132
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The American Society of Hematology
record_format MEDLINE/PubMed
spelling pubmed-104241322023-08-15 Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia Rankine-Mullings, Angela Keenan, Russell Chakravorty, Subarna Inusa, Baba Telfer, Paul Velangi, Mark Ware, Russell E. Moss, Jon J. Lloyd, Adam L. Edwards, Sarah Mulla, Hussain Blood Adv Research Letter The American Society of Hematology 2023-05-15 /pmc/articles/PMC10424132/ /pubmed/37171600 http://dx.doi.org/10.1182/bloodadvances.2023010099 Text en © 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Research Letter
Rankine-Mullings, Angela
Keenan, Russell
Chakravorty, Subarna
Inusa, Baba
Telfer, Paul
Velangi, Mark
Ware, Russell E.
Moss, Jon J.
Lloyd, Adam L.
Edwards, Sarah
Mulla, Hussain
Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title_full Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title_fullStr Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title_full_unstemmed Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title_short Efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
title_sort efficacy, safety, and pharmacokinetics of a new, ready-to-use, liquid hydroxyurea in children with sickle cell anemia
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424132/
https://www.ncbi.nlm.nih.gov/pubmed/37171600
http://dx.doi.org/10.1182/bloodadvances.2023010099
work_keys_str_mv AT rankinemullingsangela efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT keenanrussell efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT chakravortysubarna efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT inusababa efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT telferpaul efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT velangimark efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT warerusselle efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT mossjonj efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT lloydadaml efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT edwardssarah efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia
AT mullahussain efficacysafetyandpharmacokineticsofanewreadytouseliquidhydroxyureainchildrenwithsicklecellanemia